Source author record

Guadalupe Gómez Melis

Guadalupe Gómez Melis appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
4topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

Semiparametric estimation of GLMs with interval-censored covariates via an augmented Turnbull estimator

Interval-censored covariates are frequently encountered in biomedical studies, particularly in time-to-event data or when measurements are subject to detection or quantification limits. Yet, the estimation of regression models with interval-censored covariates remains methodologically underdeveloped. In this article, we address the estimation of generalized linear models when one covariate is subject to interval censoring. We propose a likelihood-based approach, GELc, that builds upon an augmented version of Turnbull's nonparametric estimator for interval-censored data. We prove that the GELc estimator is consistent and asymptotically normal under mild regularity conditions, with available standard errors. Simulation studies demonstrate favorable finite-sample performance of the estimator and satisfactory coverage of the confidence intervals. Finally, we illustrate the method using two real-world applications: the AIDS Clinical Trials Group Study 359 and an observational nutrition study on circulating carotenoids. The proposed methodology is available as an R package at github.com/atoloba/ICenCov.

preprint2020arXiv

Decision tool and Sample Size Calculator for Composite Endpoints

Summary points: - This article considers the combination of two binary or two time-to-event endpoints to form the primary composite endpoint for leading a trial. - It discusses the relative efficiency of choosing a composite endpoint over one of its components in terms of: the frequencies of observing each component; the relative treatment effect of the tested therapy; and the association between both components. - We highlight the very important role of the association between components in choosing the most efficient endpoint to use as primary. - For better grounded future trials, we recommend trialists to always reporting the association between components of the composite endpoint. - Common fallacies to note when using composite endpoints: i) composite endpoints always imply higher power; ii) treatment effect on the composite endpoint is similar to the average effects of its components; and iii) the probability of observing the primary endpoint increases significantly.